MAPT and proteostasis deficiencies: The ability to predict TDP-43 and tau pathology using neuroimaging is crucial, as it is likely these proteinopathies require therapeutics with distinct mechanisms of action, thus allowing for precision medicine approaches such as pathology-based treatment.